MedPath

Mobile health platform development after child birth.

Not yet recruiting
Conditions
Immediate postpartum Patients Z392Encounter for routine postpartum follow-up
Encounter for routine postpartum follow-up,
Registration Number
CTRI/2021/01/030572
Lead Sponsor
Dr Rashmi Bagga
Brief Summary

In phase 2 we will evaluate the feasibility and acceptability of two intervention component using a controlled 4 arm factorial design (n=160, 40 per arms)

1. Real time mobile voice information and support group alone 2. Asynchronous/on demand text based support group only 3. Real time mobile voice information and support group plus asynchronous/ on demand text based support group. Feasibility and acceptability will be assessed by back end data, surveys, IDIs with 30 participants and moderators.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
160
Inclusion Criteria
  • Postnatal 2.
  • 18+ years old, 3.
  • postpartum period up to 2 weeks.
Exclusion Criteria
  • women below 18 years of age 2.
  • Women with high risk pregnancies 2.
  • Women who delivered preterm, suffer severe maternal complications or they or their baby are otherwise sick in the first week.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Feasibility and acceptability will be assessed via back-endAfter 6 months of intervention
data, surveys, and IDIs with purposively selected participants and moderators.After 6 months of intervention
Secondary Outcome Measures
NameTimeMethod
MCH health-related knowledge, behaviors and outcomes including exclusive breastfeeding, immunization, family planning uptake, postnatal visits, mental health and empowerment.After 6 months

Trial Locations

Locations (1)

PGIMER, Chandigarh

🇮🇳

Chandigarh, CHANDIGARH, India

PGIMER, Chandigarh
🇮🇳Chandigarh, CHANDIGARH, India
Rashmi Bagga
Principal investigator
9872494602
rashmibagga@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.